image credit- shutterstock
Orchid Pharma, Chennai-based company, has announced the formation of Orchid AMS (Antimicrobial Solutions), a dedicated division focused on helping address the critical challenge of Antimicrobial Resistance (AMR) in India. This strategic move aims to address the growing threat of AMR in India and globally through innovative products, comprehensive support programmes, and digital solutions.
Orchid AMS will spearhead the company’s efforts to combat AMR through a comprehensive approach encompassing innovative product development, robust support programmes, and advanced digital solutions. The new entity aims to partner with over 2,500-3,000 hospitals and healthcare institutions in the next two to three years, to implement effective antimicrobial stewardship programmes (AMSPs).
To mark this significant initiative, the company is hosting a series of sessions aimed at providing a platform for healthcare professionals, policymakers, and industry experts to engage in crucial discussions on AMR and the role of antimicrobial stewardship.
In the first phase of its outreach, Orchid AMS will cover Delhi, Mumbai, Bangalore, Chennai, Hyderabad, Vishakhapatnam, Coimbatore, Kochi, Thiruvananthapuram, Ahmedabad, Pune, Jaipur, Chandigarh.
Orchid AMS will take lead in Antimicrobial Resistance wholistically through innovative solutions bucketed under five initiatives:
